Table 5.
Area of care | Process of care indicator | p-value | Pairwise comparison of models: OR [95% CI] | ||
---|---|---|---|---|---|
Blended Capitation vs. FFS |
CHC vs. FFS |
Blended Capitation vs. CHC |
|||
Dyslipidemia | Lipid profile | 0.30 | 1.2 [0.9-1.6] |
1.0 [0.7-1.4] |
1.2 [0.8-1.7] |
Lipid lowering drug | 0.60 | 1.0 [0.7-1.5] |
0.8 [0.5-1.2] |
1.3 [0.8-2.3] |
|
Diabetes | 2 HbA1c tests | 0.0008* | 1.9 [1.3-2.8]† |
2.5 [1.4-4.4]† |
0.8 [0.4-1.4] |
Chronic Kidney Disease | eGFR | 0.66 | 1.4 [0.7-2.7] |
1.1 [0.4-3.1] |
1.3 [0.4-4.1] |
Hypertension | 2 blood pressure measures | 0.80 | 1.1 [0.7-1.7] |
1.2 [0.8-1.8] |
0.9 [0.6-1.4] |
Anti-hypertensive drug | 0.70 | 0.9 [0.6-1.3] |
0.8 [0.5-1.4] |
1.0 [0.6-1.8] |
|
Weight | Waist circumference | 0.003* | 4.8 [2.4-9.7]† |
1.9 [0.8-4.3] |
2.6 [1.1-5.8] |
Smoking advice | 0.001* | 2.6 [1.6-4.3]† |
1.6 [0.9-3.0] |
1.6 [0.9-3.1] |
|
Smoking Cessation | Smoking program referral | 0.20 | 2.5 [1.0-6.2] |
1.4 [0.6-3.3] |
1.8 [0.7-4.3] |
Smoking drug therapy | 0.005* | 2.1 [1.3-3.3]† |
0.8 [0.4-1.6] |
2.7 [1.5-4.9]† |
* p < 0.05: Indicates that payment model has a significant effect on the delivery of the specified indicator
† p < 0.017: p-value limit for between group comparisons was corrected using a Bonferroni correction factor
OR = Odds Ratio, CI = 95% confidence interval on odds ratio